Your browser is no longer supported. Please, upgrade your browser.
Settings
DEPO Depomed, Inc. daily Stock Chart
DEPO [NASD]
Depomed, Inc.
Index- P/E- EPS (ttm)-1.22 Insider Own0.50% Shs Outstand60.89M Perf Week-3.89%
Market Cap1.20B Forward P/E13.31 EPS next Y1.49 Insider Trans-24.59% Shs Float60.65M Perf Month5.72%
Income-73.90M PEG- EPS next Q0.37 Inst Own- Short Float21.86% Perf Quarter-1.20%
Sales437.50M P/S2.75 EPS this Y-161.40% Inst Trans0.72% Short Ratio11.77 Perf Half Y20.92%
Book/sh4.86 P/B4.07 EPS next Y23.03% ROA-5.60% Target Price23.42 Perf Year-30.39%
Cash/sh1.93 P/C10.23 EPS next 5Y19.00% ROE-23.60% 52W Range12.25 - 29.50 Perf YTD9.05%
Dividend- P/FCF10.44 EPS past 5Y78.69% ROI-0.30% 52W High-32.98% Beta1.03
Dividend %- Quick Ratio1.00 Sales past 5Y33.50% Gross Margin80.20% 52W Low61.39% ATR0.78
Employees494 Current Ratio1.10 Sales Q/Q23.50% Oper. Margin-4.10% RSI (14)43.40 Volatility4.27% 3.99%
OptionableYes Debt/Eq0.00 EPS Q/Q52.30% Profit Margin-16.90% Rel Volume0.91 Prev Close20.69
ShortableYes LT Debt/Eq2.43 EarningsAug 03 AMC Payout- Avg Volume1.13M Price19.77
Recom2.20 SMA20-4.06% SMA50-0.03% SMA20010.86% Volume1,026,009 Change-4.45%
Jul-27-16Downgrade Piper Jaffray Overweight → Neutral
Jul-07-16Downgrade UBS Buy → Neutral $20
May-27-16Reiterated Mizuho Buy $19 → $23
May-09-16Upgrade Mizuho Neutral → Buy $19
Apr-11-16Reiterated Mizuho Neutral $14 → $18
Mar-24-16Reiterated Mizuho Neutral $16 → $14
Mar-24-16Initiated Northland Capital Outperform
Mar-10-16Initiated Leerink Partners Outperform $21
Feb-25-16Reiterated Mizuho Buy $19 → $16
Feb-24-16Reiterated WallachBeth Buy $33 → $27
Feb-23-16Reiterated RBC Capital Mkts Sector Perform $26 → $24
Feb-08-16Initiated Piper Jaffray Overweight
Jan-07-16Initiated Mizuho Neutral $19
Dec-03-15Resumed Morgan Stanley Equal-Weight $21
Nov-11-15Upgrade WallachBeth Hold → Buy $33
Nov-11-15Reiterated ROTH Capital Buy $21 → $24
Nov-04-15Initiated Cantor Fitzgerald Buy
Oct-21-15Reiterated RBC Capital Mkts Sector Perform $32 → $26
Jul-30-15Downgrade RBC Capital Mkts Outperform → Sector Perform $26 → $32
Jul-24-15Reiterated WallachBeth Hold $26 → $33
Aug-17-16 01:21PM  Infoblox, Depomed, Insperity: Inside Starboard Values 5 Biggest Moves of Q2 at Insider Monkey
Aug-16-16 06:31PM  Why a hedge fund wants this East Bay drug company to run like Olive Garden at bizjournals.com
Aug-12-16 10:30AM  Depomed, Inc. :DEPO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 01:04PM  DEPOMED INC Financials
Aug-10-16 12:36PM  5 stocks to watch at MarketWatch
05:50AM  [$$] Drugmakers hooked on $10bn opioid habit at Financial Times
Aug-08-16 02:03PM  ETFs with exposure to Depomed, Inc. : August 8, 2016
Aug-05-16 08:08AM  Depomed, Inc. breached its 50 day moving average in a Bullish Manner : DEPO-US : August 5, 2016
Aug-04-16 01:22AM  Edited Transcript of DEPO earnings conference call or presentation 3-Aug-16 8:30pm GMT
Aug-03-16 05:35PM  Depomed reports 2Q loss
04:30PM  Depomed Inc Earnings Call scheduled for 4:30 pm ET today
04:09PM  DEPOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Depomed Reports Second Quarter 2016 Financial Results GlobeNewswire
09:05AM  GlaxoSmithKlines Consumer Healthcare Grows in 2Q16
07:07AM  Q2 2016 Depomed Inc Earnings Release - After Market Close
Jul-27-16 04:05PM  Depomed to Report Second Quarter Fiscal Year 2016 Financial Results on Wednesday, August 3, 2016 GlobeNewswire
06:34AM  DepoMed downgraded by Piper Jaffray
Jul-26-16 09:13AM  Starboard Delivers Letter To Depomed Shareholders PR Newswire
Jul-18-16 01:34PM  Depomed Announces Patent Trial and Appeal Board Denial of Inter Partes Review of NUCYNTA Patent PR Newswire
Jul-15-16 09:05AM  Coverage Initiated on Select Drug Manufacturer Stocks
Jul-07-16 04:24PM  Depomed Downgraded On Weakness In Base Business, Stock Run-Up -8.71%
Jul-06-16 08:00AM  Depomed to Present at the Cantor Fitzgerald Healthcare Conference GlobeNewswire
Jun-28-16 08:33AM  Depomed, Inc. breached its 50 day moving average in a Bearish Manner : DEPO-US : June 28, 2016 +5.95%
Jun-24-16 09:45AM  Depomed to call special meeting of shareholders on Oct 28
06:03AM  DEPOMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-23-16 04:05PM  Depomed Proposes to Call Special Meeting of Shareholders on October 28, 2016 Following Outcome of NUCYNTA Patent Litigation GlobeNewswire
Jun-14-16 04:00PM  Depomed to Present at the JMP Securities Life Sciences Conference GlobeNewswire
09:07AM  Featured Research Report on Drug Manufacturers Stocks
Jun-02-16 09:30AM  RIMA Senvest Grows Even More Bullish On Top Holdings at Insider Monkey
May-26-16 12:42PM  [$$] Starboard Calls for Depomed Board Overhaul at The Wall Street Journal
12:26PM  Starboard seeks Depomed special shareholder meeting
11:17AM  Depomed Issues Statement in Response to Starboards Press Release GlobeNewswire
10:03AM  Starboard calls for overhaul of Depomed board at MarketWatch
09:52AM  StarBoard requests Depomed special shareholder meeting Reuters
09:08AM  Starboard Delivers Letter to Depomed Shareholders PR Newswire
May-25-16 08:55AM  Top Analyst Upgrades and Downgrades: Applied Materials, Best Buy, Nokia, CSC, HPE, Monsanto, Noble Energy, Western Digital and More at 24/7 Wall St.
May-23-16 08:05AM  10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls at 24/7 Wall St.
08:00AM  Cebranopadol Data Presented at World Institute of Pain Congress Highlight Clinically Significant Reductions in Pain, Low Abuse Deterrent Potential and a Favorable Respiratory Profile GlobeNewswire
May-20-16 04:28PM  DEPOMED INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events
May-18-16 04:45PM  Depomed Announces District Court Order Extending Stay in NUCYNTA ANDA Litigation GlobeNewswire
May-16-16 08:00AM  Depomed Announces Presentation of Cebranopadol Data at World Institute of Pain Congress GlobeNewswire
May-10-16 07:08PM  IBB: Makes Small Comeback Following a Tumble Last Week
06:00AM  'Mad Money' Lightning Round: I'm Sticking With Salesforce.com at TheStreet
May-09-16 05:30PM  Horizon Pharma Spikes On Earnings Beat; Depomed Rises On Upgrade +15.09%
05:30PM  Horizon Pharma Spikes On Earnings Beat; Depomed Rises On Upgrade at Investor's Business Daily
03:23PM  Wall Street struggles for gains as crude falls Yahoo Finance
02:58PM  Why These Five Stocks Are in Spotlight Today? at Insider Monkey
10:49AM  Depomed, Inc. :DEPO-US: Earnings Analysis: Q1, 2016 By the Numbers
07:58AM  Early movers: HCP, LC, TSN, LUV, TEVA, BRKB, DIS TWTR, FB & more at CNBC
07:58AM  Early movers: HCP, LC, TSN, LUV, TEVA, BRKB, DIS TWTR, FB & more at CNBC
May-06-16 02:45PM  Edited Transcript of DEPO earnings conference call or presentation 5-May-16 8:30pm GMT Thomson Reuters StreetEvents
01:45PM  DEPOMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
May-05-16 07:40PM  How To Follow The Best Activist Investor In The Business at Forbes
05:34PM  Depomed reports 1Q loss AP
04:30PM  Depomed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:21PM  Depomed (DEPO) Stock Slumps in After-Hours Trading on Q1 Earnings Miss at TheStreet
04:13PM  DEPOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:00PM  Depomed Reports First Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q1 2016 Depomed Inc Earnings Release - After Market Close CCBN
May-04-16 06:26PM  TABLE-Hedge fund managers' investment picks from Sohn conference Reuters
06:06PM  Sohn Conference: Jeff Smith Pitches Depomed (DEPO), Westrock (WRK) at Insider Monkey
04:24PM  Jeffrey Smith Says It's Time to Buy Depomed and WestRock: Sohn 2016 at TheStreet
02:40PM  Starboard's Smith targeting pharma firm for proxy fight at CNBC
12:40PM  What Caused DepoMed's Shares to Skyrocket 20.9% In April at Motley Fool
May-03-16 08:00AM  Depomed to Present at Healthcare Conferences in May GlobeNewswire
Apr-28-16 08:00AM  Depomed to Report First Quarter Fiscal Year 2016 Financial Results on Thursday, May 5, 2016 GlobeNewswire +5.13%
Apr-27-16 12:16PM  4 Bargain Stocks You Can Buy Today at Motley Fool
12:11PM  Sohn Preview: Starboard Value Adds Infoblox to Already Full Plate at TheStreet
Apr-25-16 12:42PM  [$$] Depomed Says Starboard Has Month to Call Shareholder Meeting at The Wall Street Journal
11:02AM  Depomed gives Starboard chance for meeting to replace board AP
07:54AM  Depomed says Starboard has a month to request for shareholder meeting Reuters
07:01AM  DEPOMED INC Files SEC form 8-K, Other Events EDGAR Online
06:30AM  Depomed Announces Record Date to Determine Shareholders Entitled to Request Special Meeting GlobeNewswire
Apr-19-16 12:24PM  Why This Hedge Fund Activist Wants to Replace Yahoos Entire Board at Fortune
Apr-18-16 03:00PM  Activist shareholder: Board change 'required' at East Bay drug company at bizjournals.com
Apr-16-16 08:58PM  Depomed Inc (DEPO): Starboard Value Snatches Up Another 1.5 Million Shares at Insider Monkey
Apr-15-16 02:03PM  Activist Investor Reaffirms Stance On Depomed, Says 'Meaningful Change Is Needed'
12:10PM  East Bay drug company avoids 'distracting' shareholder fight by withdrawing reincorporation plan at bizjournals.com
10:43AM  [$$] Starboard to Continue Proxy Fight Against Depomed at The Wall Street Journal
10:15AM  Starboard presses on with push to replace Depomed's board
09:40AM  Stocks to Watch: Citigroup, Mitel Networks, Bats Global at The Wall Street Journal
07:56AM  Starboard says to continue to push for board change at Depomed
07:15AM  Starboard Comments On Depomed's Decision To Withdraw Its Reincorporation Proposal PR Newswire
Apr-14-16 07:20PM  After Hours: Apple App Store Changes, Valeant Mulls Options, BATS IPO
06:33PM  [$$] Depomed Abandons Plans to Reincoporate in Delaware at The Wall Street Journal
05:38PM  Depomed not to reincorporate to Delaware from California
04:56PM  Depomed Announces Decision Not To Pursue Proposed Reincorporation PR Newswire
09:45AM  Why You Should Pay Attention to Activist Jeff Smiths Latest Moves at Insider Monkey
Apr-13-16 08:06PM  [$$] Depomed Faces an Uphill Slog on Starboard Campaign at The Wall Street Journal
Apr-12-16 04:01PM  Why One Activist Thinks This Company Is Too Cheap at Motley Fool
10:37AM  Dealpolitik: Starboard Campaign Is Bitter Pill for Depomed at The Wall Street Journal
Apr-11-16 04:15PM  A Look Into Jeff Smith, John Paulson & Two Other Investors Latest Moves at Insider Monkey
08:11AM  Depomed, Inc. breached its 50 day moving average in a Bullish Manner : DEPO-US : April 11, 2016
12:18AM  [$$] Business Watch at The Wall Street Journal
Apr-08-16 06:01PM  East Bay drug company pushed again to sell this time from the inside at bizjournals.com +13.00%
05:08PM  Starboard attempts a coup at Depomed
02:32PM  Depomed Responds To Activist Investor, Notes Starboard Has Made No Contact With Management
02:06PM  Starboard Value Takes Aim at a New Activist Target, Plus All the Details on 3 Other Filings at Insider Monkey
12:23PM  Activist Sinks Teeth Into Depomed, Send Shares Soaring 12% Today at Motley Fool
11:06AM  Starboard urges Depomed board to pursue a potential sale
Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. The company also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, it is involved in the clinical development of IW-3718 refractory gastroesophageal reflux disease program using Acuform drug delivery technology; and Cebranopadol, a molecule for the treatment of chronic nociceptive and neuropathic pain. Depomed, Inc. sells its Gralise products to wholesalers and retail pharmacies. The company also has a portfolio of license agreements based on its proprietary Acuform gastroretentive drug delivery technology with Mallinckrodt Inc.; Ironwood Pharmaceuticals, Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 1995 and is headquartered in Newark, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moretti August JChief Financial Officer & SVPAug 10Option Exercise12.693,29741,83924,977Aug 11 05:01 PM
Moretti August JChief Financial Officer & SVPAug 10Sale21.405,000107,00021,680Aug 11 05:01 PM
Vargas Thadd MSenior VP, BDAug 10Sale20.9226,290549,98784,336Aug 11 04:56 PM
Vargas Thadd MSenior VP, BDMay 23Sale20.0015,000300,000109,297May 25 04:46 PM
Vargas Thadd MSenior VP, BDMay 10Sale17.6415,000264,600124,297May 10 05:14 PM
Moretti August JChief Financial Officer & SVPMay 09Sale18.005,00090,00022,879May 09 04:48 PM
Schoeneck James APresident and CEOMar 18Option Exercise3.9430,483120,09436,848Mar 21 04:17 PM
Vargas Thadd MSenior VP, BDMar 11Sale16.0023,000368,000137,737Mar 11 06:40 PM
Vargas Thadd MSVP, Business DevelopmentMar 02Sale15.1810,000151,780160,737Mar 04 08:28 PM
Vargas Thadd MSVP, Business DevelopmentJan 11Option Exercise7.1218,180129,442170,737Jan 12 07:10 PM
Schoeneck James APresident and CEODec 28Option Exercise6.116,36538,8906,365Dec 28 07:24 PM
Moretti August JChief Financial Officer & SVPDec 16Option Exercise5.355,00026,75026,319Dec 17 12:31 PM
Moretti August JChief Financial Officer & SVPDec 03Sale18.1115,000271,59721,319Dec 03 06:32 PM
Schoeneck James APresident and CEOSep 29Option Exercise6.4263,561408,15863,561Sep 29 07:24 PM